Search Results - "proteomics"
Suggested Topics within your search.
Suggested Topics within your search.
- methods
- Proteomics 51
- Methodology 29
- Biochemical markers 21
- Biomarkers 21
- Proteome 20
- genetics 18
- analysis 17
- Systems Biology 15
- metabolism 15
- Proteins 14
- Computational Biology 13
- Diseases 12
- Cancer 11
- diagnosis 11
- Genomics 10
- Biological models 9
- Data processing 9
- Genetic aspects 9
- physiology 9
- Cardiovascular Diseases 8
- chemistry 8
- Aging 6
- Cardiovascular system 6
- Cellular signal transduction 6
- Chemical modification 6
- Combinatorial Chemistry Techniques 6
- Computational biology 6
- Databases, Genetic 6
- Escherichia coli 6
-
1
The proteomic revolution
Published 2012Table of Contents: “…Contents: The proteomic revolution -- Proteomics is the best measure of phenotype (biomarkers) -- Slow Off-rate Modified Aptamers (SOMAmers) are breakthrough protein binding reagents -- SOMAmers are multiplexed to perform SOMAscan assay, which measures >1000 proteins in small sample volumes using DNA measurement tools to identify and quantify proteins bound by SOMAmers -- Applications of SOMAscan to date include finding valid protein biomarkers for lung cancer, cardiovascular risk, pre-term birth, pancreatic cancer, mesothelioma, and many other diseases and conditions -- Ability to do comprehensive longitudinal proteomics studies will revolutionize medicine.…”
Get full text
Series
Electronic Video -
2
The proteomic revolution
Published 2022Table of Contents: “…Contents: The proteomic revolution -- Proteomics is the best measure of phenotype (biomarkers) -- Slow Off-rate Modified Aptamers (SOMAmers) are breakthrough protein binding reagents -- SOMAmers are multiplexed to perform SOMAscan assay, which measures >1000 proteins in small sample volumes using DNA measurement tools to identify and quantify proteins bound by SOMAmers -- Applications of SOMAscan to date include finding valid protein biomarkers for lung cancer, cardiovascular risk, pre-term birth, pancreatic cancer, mesothelioma, and many other diseases and conditions -- Ability to do comprehensive longitudinal proteomics studies will revolutionize medicine.…”
Get full text
Series
Electronic Video -
3
The chloroplast proteome
Published 2021Table of Contents: “…Contents: What is proteomics and what does it measure? -- Protein identification by mass spectrometry -- The problem of complex mixtures and protein identification -- Quantitative proteomics and stable isotope labeling -- Intact protein mass measurements and top-down proteomics.…”
Get full text
Series
Electronic Video -
4
The chloroplast proteome
Published 2021Table of Contents: “…Contents: What is proteomics and what does it measure? -- Protein identification by mass spectrometry -- The problem of complex mixtures and protein identification -- Quantitative proteomics and stable isotope labeling -- Intact protein mass measurements and top-down proteomics.…”
Get full text
Series
Electronic Video -
5
The proteomic revolution
Published 2022Table of Contents: “…Contents: The proteomic revolution -- Proteomics is the best measure of phenotype (biomarkers) -- Slow Off-rate Modified Aptamers (SOMAmers) are breakthrough protein binding reagents -- SOMAmers are multiplexed to perform SOMAscan assay, which measures >1000 proteins in small sample volumes using DNA measurement tools to identify and quantify proteins bound by SOMAmers -- Applications of SOMAscan to date include finding valid protein biomarkers for lung cancer, cardiovascular risk, pre-term birth, pancreatic cancer, mesothelioma, and many other diseases and conditions -- Ability to do comprehensive longitudinal proteomics studies will revolutionize medicine.…”
Get full text
Series
Electronic Video -
6
Proteomic technologies and targets an overview /
Published 2013Table of Contents: “…Contents: Introduction -- The relationship between genome and proteome -- Why should we analyse the proteome? -- Challenges in proteome analysis -- Dynamic range of the proteome -- Complexity of the proteome -- Spatiotemporal organisation -- Dynamic changes in protein concentrations and modifications -- Technologies for analysing the proteome -- Mass spectrometry -- Protein arrays -- Imaging -- Data analysis -- The applications of clinical proteomics -- Biomarkers -- Systems biology approaches.…”
Get full text
Series
Electronic Video -
7
Proteomics in cardiovascular disease clinical considerations /
Published 2013Table of Contents: “…Contents: Systems biology -- Definition of proteomics -- Proteomics: rationale and practical aspects -- Proteomics in cardiovascular pathophysiology -- Proteomics to detect biomarkers of cardiovascular disease -- Urinary proteomics using capillary electrophoresis / mass spectrometry -- Proteomics of coronary artery disease -- Proteomics of pre-eclampsia -- Proteomics of other cardiovascular diseases: stroke, heart failure, diabetic nephropathy.…”
Get full text
Series
Electronic Video -
8
Proteomics in kidney disease clinical considerations /
Published 2013Table of Contents: “…Contents: Proteomics for clinical use -- Available and applied single risk marker strategies in nephrology based on hypothesis driven biomarker search -- Open or unbiased multimarker approaches including plasma and urine proteomics -- Examples from different renal diseases -- Data from cross sectional and longitudinal studies -- Proteomics may provide insight into disease pathology -- Proteomics may provide risk stratification for clinical trials -- Example: intervention trial for type 2 diabetic subjects with high risk urinary proteomic pattern.…”
Get full text
Series (Clinical proteomics)
Series (Kidney in health and disease)
Electronic Video -
9
Proteomics in cardiovascular disease clinical considerations /
Published 2013Table of Contents: “…Contents: Systems biology -- Definition of proteomics -- Proteomics: rationale and practical aspects -- Proteomics in cardiovascular pathophysiology -- Proteomics to detect biomarkers of cardiovascular disease -- Urinary proteomics using capillary electrophoresis / mass spectrometry -- Proteomics of coronary artery disease -- Proteomics of pre-eclampsia -- Proteomics of other cardiovascular diseases: stroke, heart failure, diabetic nephropathy.…”
Get full text
Series
Electronic Video -
10
Proteomics in kidney disease clinical considerations /
Published 2013Table of Contents: “…Contents: Proteomics for clinical use -- Available and applied single risk marker strategies in nephrology based on hypothesis driven biomarker search -- Open or unbiased multimarker approaches including plasma and urine proteomics -- Examples from different renal diseases -- Data from cross sectional and longitudinal studies -- Proteomics may provide insight into disease pathology -- Proteomics may provide risk stratification for clinical trials -- Example: intervention trial for type 2 diabetic subjects with high risk urinary proteomic pattern.…”
Get full text
Series (Clinical proteomics)
Series (Kidney in health and disease)
Electronic Video -
11
Proteomic technologies and targets an overview /
Published 2013Table of Contents: “…Contents: Introduction -- The relationship between genome and proteome -- Why should we analyse the proteome? -- Challenges in proteome analysis -- Dynamic range of the proteome -- Complexity of the proteome -- Spatiotemporal organisation -- Dynamic changes in protein concentrations and modifications -- Technologies for analysing the proteome -- Mass spectrometry -- Protein arrays -- Imaging -- Data analysis -- The applications of clinical proteomics -- Biomarkers -- Systems biology approaches.…”
Get full text
Series
Electronic Video -
12
Proteomics in cardiovascular disease clinical considerations /
Published 2013Table of Contents: “…Contents: Systems biology -- Definition of proteomics -- Proteomics: rationale and practical aspects -- Proteomics in cardiovascular pathophysiology -- Proteomics to detect biomarkers of cardiovascular disease -- Urinary proteomics using capillary electrophoresis / mass spectrometry -- Proteomics of coronary artery disease -- Proteomics of pre-eclampsia -- Proteomics of other cardiovascular diseases: stroke, heart failure, diabetic nephropathy.…”
Get full text
Series
Electronic Video -
13
Proteomics in kidney disease clinical considerations /
Published 2013Table of Contents: “…Contents: Proteomics for clinical use -- Available and applied single risk marker strategies in nephrology based on hypothesis driven biomarker search -- Open or unbiased multimarker approaches including plasma and urine proteomics -- Examples from different renal diseases -- Data from cross sectional and longitudinal studies -- Proteomics may provide insight into disease pathology -- Proteomics may provide risk stratification for clinical trials -- Example: intervention trial for type 2 diabetic subjects with high risk urinary proteomic pattern.…”
Get full text
Series (Clinical proteomics)
Series (Kidney in health and disease)
Electronic Video -
14
Proteomic technologies and targets an overview /
Published 2013Table of Contents: “…Contents: Introduction -- The relationship between genome and proteome -- Why should we analyse the proteome? -- Challenges in proteome analysis -- Dynamic range of the proteome -- Complexity of the proteome -- Spatiotemporal organisation -- Dynamic changes in protein concentrations and modifications -- Technologies for analysing the proteome -- Mass spectrometry -- Protein arrays -- Imaging -- Data analysis -- The applications of clinical proteomics -- Biomarkers -- Systems biology approaches.…”
Get full text
Series
Electronic Video -
15
Clinical proteomics in gastrointestinal cancers
Published 2013Subjects: Get full text
Series
Electronic Video -
16
A concept for multi-marker approaches in clinical proteomics
Published 2013Subjects: Get full text
Series
Electronic Video -
17
Clinical proteomics in the investigation of bladder cancer
Published 2013Table of Contents: “…Contents: Clinical proteomics: principles of experimental design and data reporting -- Clinical needs in bladder cancer -- Bladder Cancer Biomarker discovery in urine using proteomics approaches -- How to progress towards implementation.…”
Get full text
Series
Electronic Video -
18
Clinical proteomics in neurodegenerative disease
Published 2013Table of Contents: “…Contents: Neurodegenerative disease -- Dementia -- Alzheimer´s -- Clinical use of proteomic methods for diagnosis and biomarker development -- An example: CE-MS in Alzheimer research -- Scope, limits, pitfalls, prospects.…”
Get full text
Series
Electronic Video -
19
Clinical proteomics in gastrointestinal cancers
Published 2013Subjects: Get full text
Series
Electronic Video -
20
Clinical proteomics in neurodegenerative disease
Published 2013Table of Contents: “…Contents: Neurodegenerative disease -- Dementia -- Alzheimer´s -- Clinical use of proteomic methods for diagnosis and biomarker development -- An example: CE-MS in Alzheimer research -- Scope, limits, pitfalls, prospects.…”
Get full text
Series
Electronic Video